DigestRedComo funciona
Red
/
Empresas
F.
No verificado

F. Hoffmann-La Roche Ltd

Sobre qué escribimos

Anuncios brevesFarmacéuticaPublicidad/Marketing/Medios de comunicación/Comunicación

102 Comunicados de prensa

Ver todos los comunicados de prensa
01/12/2025
Farmacéutica
Anuncios breves
Roche receives FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough (pertussis)
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
18/11/2025
Farmacéutica
Anuncios breves
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
17/11/2025
Farmacéutica
Anuncios breves
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s giredestrant becomes the first oral SERD to show superior invasive disease-free survival in early breast cancer
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
09/11/2025
Farmacéutica
Anuncios breves
Publicidad/Marketing/Medios de comunicación/Comunicación
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s fenebrutinib shows unprecedented positive Phase III results as the potential first and only BTK inhibitor in both relapsing and primary progressive multiple sclerosis
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
03/11/2025
Farmacéutica
Anuncios breves
Publicidad/Marketing/Medios de comunicación/Comunicación
Roche to present new data from its broad and innovative haematology portfolio at ASH 2025
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
02/11/2025
Farmacéutica
Anuncios breves
Publicidad/Marketing/Medios de comunicación/Comunicación
Positive phase III data for Roche’s Gazyva/Gazyvaro show significant reduction in disease activity for systemic lupus erythematosus
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
29/10/2025
Farmacéutica
Anuncios breves
Roche purchases shares in tender offer for 89bio, Inc
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
28/10/2025
Farmacéutica
Anuncios breves
Roche receives CE mark for novel automated high-throughput Elecsys Dengue Ag test to diagnose dengue
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
27/10/2025
Farmacéutica
Anuncios breves
Publicidad/Marketing/Medios de comunicación/Comunicación
Positive phase III results for Roche’s Gazyva/Gazyvaro in children and young adults with idiopathic nephrotic syndrome
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
22/10/2025
Farmacéutica
Anuncios breves
Changes to the Roche Enlarged Corporate Executive Committee
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0